Literature DB >> 8081952

Gene transfer into the mammalian kidney: direct retrovirus-transduction of regenerating tubular epithelial cells.

R J Bosch1, A S Woolf, L G Fine.   

Abstract

Gene transfer using retroviral vectors requires cell replication for insertion of the DNA provirus. Since the mitotic index of the mammalian kidney is very low, renal tubular cell replication was induced in adult rats as part of a regenerative response to the nephrotoxic injury induced by an intraperitoneal injection of folic acid. At 48 h, at the time of maximum 3H-thymidine incorporation, the left kidney was directly injected with a suspension of the Psi2 BAG retrovirus which transduces the beta-galactosidase gene. At 1-7 weeks after virus administration the left kidney was harvested. Using the polymerase chain reaction to amplify viral DNA, successful gene transfer was achieved in 8 of 15 kidneys. In 6 of 10 kidneys assessed histochemically positive staining for beta-galactosidase activity was detected in the cytoplasm of tubular epithelial cells. There was no evidence of gene expression in glomerular, vascular or endothelial cells. All analyses were negative in vehicle-injected kidneys and in the kidneys of animals which did not receive pretreatment with folic acid. These studies demonstrate the feasibility of gene transfer into the adult kidney provided that replication of specific cell types can be achieved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8081952

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  13 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

Review 2.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

3.  Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype.

Authors:  C W Heilig; L A Concepcion; B L Riser; S O Freytag; M Zhu; P Cortes
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 4.  Genetically engineered kidneys.

Authors:  A S Woolf; L G Fine
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Macrophage growth factors introduced into the kidney initiate renal injury.

Authors:  T Naito; H Yokoyama; K J Moore; G Dranoff; R C Mulligan; V R Kelley
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

6.  Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha.

Authors:  Hai-Tao Yuan; Xiao-Zhong Li; Jolanta E Pitera; David A Long; Adrian S Woolf
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo.

Authors:  M Kitamura; S Taylor; R Unwin; S Burton; F Shimizu; L G Fine
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

8.  Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome.

Authors:  Kent Doi; Asada Leelahavanichkul; Xuzhen Hu; Karen L Sidransky; Hua Zhou; Yan Qin; Christoph Eisner; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

Review 9.  Liposome-mediated gene therapy in the kidney.

Authors:  Keiichi Ito; Jie Chen; Tomohiko Asano; E Darracott Vaughan; Dix P Poppas; Masamichi Hayakawa; Diane Felsen
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

10.  Evidence that retroviruses integrate into post-replication host DNA.

Authors:  M Hajihosseini; L Iavachev; J Price
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.